title: Contrast media safety-an update.
abstract: The value of contrast agents has for long been documented by their common daily use in imaging departments worldwide. In principle, they should be injected and leave the body immediately after use in the same condition or undergo natural metabolism without making any harm to the patient. However, this is not the case. It is of utmost importance to reduce the prevalence to as close as possible to zero. This can be done by identifying the patients at risk before administration of contrast agents. For acute non-renal adverse reactions, it is also important to be prepared for treating them instantly. The current review is a short state of the art regarding adverse reactions to contrast agents.
authors.affiliation: Department of Diagnostic Sciences, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark. hentho01@heh.regionh.dk
authors.forename: Henrik S
authors.initials: HS
authors.lastname: Thomsen
mesh_terms: D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control; D008279:Magnetic Resonance Imaging; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced; D011859:Radiography; D012307:Risk Factors; D013971:Thyrotoxicosis / Q000139:chemically induced; D014463:Ultrasonography
chemical_list: D003287:Contrast Media